Bill number does not exist. Enter a vaild keyword.

Legislation

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Health - Mifepristone - Administration
Sponsored by
Delegates Cox, Boteler, Impallaria, Otto, and Reilly
Status
In the House - Hearing 3/08 at 1:00 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring the Maryland Department of Health to adopt certain regulations regarding the administration of mifepristone; requiring that mifepristone be provided by or under the supervision of a physician who meets certain qualifications and conditions; requiring each provider of mifepristone to make certain certifications and disclose certain information; establishing a certain penalty; requiring the Department to report to the General Assembly on or before December 1, 2019, and each December 1 thereafter; etc.
Details
Bill File Type: Regular
Effective Date(s): October 1, 2019
Legislation History
Chamber
House
Calendar Date
2/08/2019
Legislative Date
2/08/2019
Action
First Reading Health and Government Operations
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Health - Mifepristone - Administration
Proceedings
Chamber
House
Calendar Date
2/19/2019
Legislative Date
2/19/2019
Action
Hearing 3/08 at 1:00 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
House 2/08/2019 2/08/2019 First Reading Health and Government Operations
Text - First - Health - Mifepristone - Administration
House 2/19/2019 2/19/2019 Hearing 3/08 at 1:00 p.m.
Last Updated: 2/3/2020 2:31 PM
Click to return on the top page